Arado, Teresita A.

HRN: 07-00-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/01/2026
05/07/2026
IV
500mg
Q8
Anterior Mediastinal Mass
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: